XBI - SPDR S&P Biotech ETF (USD) (US78464A8707)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

Alle auswählen Alle zurücksetzen

Speichern Schließen

(%)

US78464A8707

XBI ISIN

Exchange Traded Funds (ETF)

Fondstyp

SPDR State Street Global Advisors

Anbieter

133,78 USD

NAV pro Aktie | 12/06/2026

31/01/2006

Startdatum

4 Wiederholungen pro Jahr

Ausschüttung von Dividenden

CEOILS

CFI

XBI

Ticker

Formed

Status

Equity

Investitionsobjekt

Biotech

Sektor

USA

Geographie

S&P Biotechnology Select Industry Index

Benchmark

0.35 %

Gesamtkostenquote

8.297,62 Mio. USD

Gesamtes Fondsvermögen | 12/06/2026

8.297,62 Mio. USD

Aktien-Anlageklasse Volumen | 12/06/2026

Nein

UCITS

1 / 3 (11/09/2015)

Split

Rendite auf 12/06/2026, NYSE Arca

YTD

5,06 %
1M

-7,93 %
3M

1,65 %
6M

11,2 %
1J

62,15 %
3J

51,47 %
5J

0,91 %
10J

143,19 %

Zum Börsenpreis einschliesslich Einkommenszahlungen

Letzte Daten zum

Zum Vergleichen hinzufügen

Kurse (XBI)

Entdecken Sie die umfangreichste Datenbank

1 000 000

Anleihen weltweit

80 234

Aktien

167 970

ETF & Funds

80 000

Indizes

Verwalten Sie Ihr Portfolio auf effizienteste Weise

Bond-Screener
Watchlist
Excel-Add-In

Zugang erhalten

Kurs-Dynamik

Fund profile

The SPDR S&P Biotech ETF seeks to replicate as closely as possible the price and yield performance of the S&P Biotechnology Select Industry Index by investing in a portfolio comprised primarily of U.S. companies in the biotechnology sector

XBI profile

The SPDR S&P Biotech ETF (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in USA. The SPDR State Street Global Advisors fund’s base currency is USD and the share class was registered 31.01.2006 with unique ISIN - US78464A8707. Main exchange is NYSE Arca and ticker symbol is XBI. The total expense ratio is 0.35%. The SPDR S&P Biotech ETF (USD) pays dividends 4 time(s) per year.

Struktur XBI auf 11/06/2026

Struktur in Excel herunterladen

Wertpapier	Wertpapier
TG THERAPEUTICS INC	1,99%
TRAVERE THERAPEUTICS INC	1,92%
ALKERMES PLC	1,88%
TWIST BIOSCIENCE CORP	1,84%
REVOLUTION MEDICINES INC	1,74%
EXELIXIS INC	1,49%
ARROWHEAD PHARMACEUTICALS IN	1,49%
KRYSTAL BIOTECH INC	1,47%
NEUROCRINE BIOSCIENCES INC	1,46%
NUVALENT INC A	1,44%
APOGEE THERAPEUTICS INC	1,39%
INCYTE CORP	1,32%
PROTAGONIST THERAPEUTICS INC	1,32%
PTC THERAPEUTICS INC	1,32%
BEAM THERAPEUTICS INC	1,31%
NATERA INC	1,3%
MADRIGAL PHARMACEUTICALS INC	1,28%
VERACYTE INC	1,27%
CYTOKINETICS INC	1,27%
MIRUM PHARMACEUTICALS INC	1,26%
HALOZYME THERAPEUTICS INC	1,24%
BIOGEN INC	1,22%
SCHOLAR ROCK HOLDING CORP	1,2%
SPYRE THERAPEUTICS INC	1,19%
KYMERA THERAPEUTICS INC	1,18%
CRISPR THERAPEUTICS AG	1,17%
ROIVANT SCIENCES LTD	1,17%
UNITED THERAPEUTICS CORP	1,16%
ARCUTIS BIOTHERAPEUTICS INC	1,16%
IMMUNOVANT INC	1,16%
ABBVIE INC	1,15%
IONIS PHARMACEUTICALS INC	1,15%
RHYTHM PHARMACEUTICALS INC	1,13%
BRIDGEBIO PHARMA INC	1,1%
AMGEN INC	1,09%
BIOMARIN PHARMACEUTICAL INC	1,07%
COGENT BIOSCIENCES INC	1,05%
VERTEX PHARMACEUTICALS INC	1,05%
ALNYLAM PHARMACEUTICALS INC	1,05%
MODERNA INC	1,03%
ULTRAGENYX PHARMACEUTICAL IN	1,02%
IMMUNITYBIO INC	1,01%
CG ONCOLOGY INC	1,01%
GILEAD SCIENCES INC	1%
ACADIA PHARMACEUTICALS INC	1%
CATALYST PHARMACEUTICALS INC	0,98%
PRAXIS PRECISION MEDICINES I	0,97%
VAXCYTE INC	0,96%
DISC MEDICINE INC	0,95%
VIKING THERAPEUTICS INC	0,93%
REGENERON PHARMACEUTICALS	0,92%
ERASCA INC	0,91%
CELCUITY INC	0,9%
VERA THERAPEUTICS INC	0,88%
SUMMIT THERAPEUTICS INC	0,87%
GRAIL INC	0,86%
DYNE THERAPEUTICS INC	0,85%
DENALI THERAPEUTICS INC	0,82%
TANGO THERAPEUTICS INC	0,81%
INSMED INC	0,81%
BIOCRYST PHARMACEUTICALS INC	0,78%
AGIOS PHARMACEUTICALS INC	0,76%
IMMUNOME INC	0,74%
RECURSION PHARMACEUTICALS A	0,72%
ORUKA THERAPEUTICS INC	0,72%
ARCUS BIOSCIENCES INC	0,69%
NURIX THERAPEUTICS INC	0,65%
IDEAYA BIOSCIENCES INC	0,64%
INTELLIA THERAPEUTICS INC	0,64%
SAREPTA THERAPEUTICS INC	0,63%
KODIAK SCIENCES INC	0,63%
UNIQURE NV	0,62%
DIANTHUS THERAPEUTICS INC	0,62%
ARDELYX INC	0,61%
BIOHAVEN LTD	0,6%
VIRIDIAN THERAPEUTICS INC	0,59%
VERICEL CORP	0,59%
MINERALYS THERAPEUTICS INC	0,58%
NOVAVAX INC	0,58%
SYNDAX PHARMACEUTICALS INC	0,58%
MANNKIND CORP	0,56%
ADMA BIOLOGICS INC	0,56%
RELAY THERAPEUTICS INC	0,55%
CELLDEX THERAPEUTICS INC	0,5%
SELLAS LIFE SCIENCES GROUP I	0,5%
CAREDX INC	0,48%
MONTE ROSA THERAPEUTICS INC	0,46%
STOKE THERAPEUTICS INC	0,45%
IOVANCE BIOTHERAPEUTICS INC	0,44%
TAYSHA GENE THERAPIES INC	0,43%
ABSCI CORP	0,4%
CAPRICOR THERAPEUTICS INC	0,4%
PALVELLA THERAPEUTICS INC	0,4%
ANAPTYSBIO INC	0,38%
INHIBRX BIOSCIENCES INC	0,38%
PRECIGEN INC	0,37%
CORVUS PHARMACEUTICALS INC	0,34%
OLEMA PHARMACEUTICALS INC	0,33%
RIGEL PHARMACEUTICALS INC	0,31%
KURA ONCOLOGY INC	0,31%

Alle anzeigen Verstecken

Andere - %